Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 5, 2012, Pages 1809-1815

  Li, Ye Xiong ^a   Wang, Hua ^a   Jin, Jing ^a   Wang, Wei Hu ^a   Liu, Qing Feng ^a   Song, Yong Wen ^a   Wang, Zhao Yang ^a   Qi, Shu Nan ^a   Wang, Shu Lian ^a   Liu, Yue Ping ^a   Liu, Xin Fan ^a   Yu, Zi Hao ^a  

^a CANCER HOSPITAL   (China)

Author keywords

NK T cell lymphoma; Prognosis; Radiotherapy; Stage I

Indexed keywords

CLINICAL OUTCOME; COMPLETE RESPONSE; CURATIVE INTENT; DISEASE PROGRESSION; HIGH DOSE; LOCAL CONTROL; LYMPH NODE; NASAL CAVITY; NK/T-CELL LYMPHOMA; ORAL CAVITY; OVERALL SURVIVAL; PARTIAL RESPONSE; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIOTHERAPY ALONE; SYSTEMATIC THERAPY; UPPER AERODIGESTIVE TRACTS;

DIAGNOSIS; DISEASE CONTROL; ONCOLOGY; SURVEYS;

RADIOTHERAPY;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; NK T CELL LYMPHOMA; NOSE CAVITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION; WALDEYER RING;

ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOID TISSUE; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; NOSE NEOPLASMS; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84858707231     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.10.040     Document Type: Article

References (42)

1. Aviles A, Diaz NR, Neri N, et al. Angiocentric nasal T/natural killer cell lymphoma: A single center study of prognostic factors in 108 patients. Clin Lab Haematol 2000;22:215-220.
2. Bossard C, Belhadj K, Reyes F, et al. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: Results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 2007;109:2183-2189. (Pubitemid 46348221)
3. Barrionuevo C, Zaharia M, Martinez MT, et al. Extranodal NK/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol 2007;15:38-44. (Pubitemid 46673314)
4. Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal NK/T-cell lymphoma: A study of 136 cases from the International Peripheral T-cell Lymphoma Project. Blood 2009;113:3931-3937.
5. Kim K, Chie EK, Kim CW, et al. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: Radiotherapy versus chemoradiotherapy. Jpn J Clin Oncol 2005;35:1-5. (Pubitemid 40450547)
6. Li YX, Yao B, Jin J, et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol 2006;24:181-189. (Pubitemid 46630511)
7. KimTM, Lee SY, JeonYK, et al. Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: A national survey of the Korean Cancer Study Group. Ann Oncol 2008;19:1477-1484.
8. Li YX, Fang H, Liu QF, et al. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood 2008;112:3057-3064.
9. Lee J, Park YH, Kim WS, et al. Extranodal nasal type NK/T-cell lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 2005;41:1402-1408. (Pubitemid 40826463)
10. Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612-618. (Pubitemid 46630424)
11. Li YX, Liu QF, Fang H, et al. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma. Clin Cancer Res 2009;15:2905-2912.
12. Chim CS, Ma SY, Au WY, et al. Primary nasal natural killer cell lymphoma: Long-term treatment outcome and relationship with the international prognostic index. Blood 2004;103:216-221.
13. You JY, Chi KH, Yang MH, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: A single institute survey in Taiwan. Ann Oncol 2004;15:618-625.
14. Li CC, Tien HF, Tang JL, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 2004;100:366-375.
15. Huang MJ, Jiang Y, Liu WP, et al. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 2008;70:166-174. (Pubitemid 350251036)
16. Yang Y, Zhang YJ, Lin XB, et al. Role of radiotherapy in the combined treatment of patients with early-stage extranodal nasal-type NK/T-cell lymphoma and analysis of prognostic factors. Chin J Radiat Oncol 2009;18:285-289.
17. Ma HH, Qian LT, Pan HF, et al. Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-celllymphoma. Med Oncol 2010;27:798-806.
18. Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment. J Clin Oncol 2000;18:54-63. (Pubitemid 30036336)
19. Kim GE, Lee SW, Chang SK, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol 2001;61:261-269. (Pubitemid 33127230)
20. Isobe K, Uno T, Tamaru JI, et al. Extranodal natural killer/T-cell lymphoma, nasal type. Cancer 2006;106:609-615.
21. Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin's lymphoma of the nasal cavity: Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer 1998;83:449-456. (Pubitemid 28354500)
22. Wang ZY, Li YX, Wang WH, et al. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents. Blood 2009;114:4771-4776.
23. Cheung MM, Chan JK, Lau WH, et al. Early stage nasal T/NK-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002;54:182-190.
24. Chan JKC, Quintanilla-Martinez L, Ferry JA, et al. Extranodal NK/T-cell lymphoma, nasal type. In: L Jaffe ES, Harris NL, Stein H, Vardiman JW, eds.World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France:IARC Press; 2008:285-288.
25. Shipp MA, Harrington DP, Anderson JR, et al. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-994. (Pubitemid 23307906)
26. Horning SH, Weller E, Kim KM, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol 2004;22:3032-3038. (Pubitemid 41103714)
27. Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998;339:21-26. (Pubitemid 28304493)
28. Aviles A, Delgado S, Ruiz H, et al. Treatment of non-Hodgkin's lymphoma ofWaldeyer's ring: Radiotherapy versus chemotherapy versus combined therapy. Eur J Cancer B Oral Oncol 1996;32B:19-23.
29. Yamaguchi M, Tobinai K, Oguchi M, et al. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 2009;27:5594-5600.
30. Kim SJ, Kim K, Kim BS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: Consortium for improving survival of lymphoma study. J Clin Oncol 2009;27:6027-6032.
31. Halperin EC, Dosoretz DE, Goodman M. Radiotherapy of polymorphic reticulosis. Br J Radiol 1982;55:645-649. (Pubitemid 12037619)
32. Smalley SR, Cupps RE, Anderson JA, et al. Polymorphic reticulosis limited to the upper aerodigestive tract: Natural history and radiotherapeutic considerations. Int J Radiat Oncol Biol Phys 1998;15:599-605.
33. Sobrevilla-Calvo P, Meneses A, Alfaro P. Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis). Acta Oncol 1993;32:69-72. (Pubitemid 23080776)
34. Chen HHW, Fong L, Su IJ, et al. Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: A retrospective analysis covering a 34-year period. Radiother Oncol 1996;38:1-6. (Pubitemid 26040262)
35. Aikemu W, Wang RZ, Li PD. A clinical study of 57 patients with extranodal natural killer/T-cell lymphoma, nasal-type. J Xinjiang Med Univ 2008;31:1507-1509.
36. Koom WS, Chung EJ, Yang WI, et al. Angiocentric T-cell and NK/T-cell lymphomas: Radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys 2004;59:1127-1137. (Pubitemid 38834307)
37. Ma X, Guo Y, Pang Z, et al. A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract. Radiother Oncol 2009;93:492-497.
38. Wu X, Li P, Zhao J, Yang X, et al. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type. Clin Oncol (R Coll Radiol) 2008;20:619-625.
39. Tomita N, Kodaira T, Tachiban H, et al. A comparison of radiation treatment plans using IMRTwith helical tomotherapy and 3D conformal radiotherapy for nasal natural killer/T-cell lymphoma. Brit J Radiol 2009;82:756-763.
40. Lee KW, Yun T, Kim DW, et al. First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma. Leuk Lymph 2006;47:1274-1282. (Pubitemid 44269634)
41. Kim TM, Park YH, Lee SY, et al. Local tumor invasiveness is more predictive of survival than international prognostic index in stage IE/IIE extranodal NK/T-cell lymphoma, nasal-type. Blood 2005;106:3785-3790.
42. Huang Y, de Reynies A, de Leval L, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal-type. Blood 2010;115:1226-1237.